See more : Suprajit Engineering Limited (SUPRAJIT.NS) Income Statement Analysis – Financial Results
Complete financial analysis of SenesTech, Inc. (SNES) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of SenesTech, Inc., a leading company in the Chemicals – Specialty industry within the Basic Materials sector.
You may be interested
- Indofood Agri Resources Ltd. (INDFF) Income Statement Analysis – Financial Results
- China Graphite Group Limited (2237.HK) Income Statement Analysis – Financial Results
- Response Oncology, Inc. (ROIX) Income Statement Analysis – Financial Results
- Pharma Mar, S.A. (0RC6.L) Income Statement Analysis – Financial Results
- New World Development Company Limited (NDVLY) Income Statement Analysis – Financial Results
SenesTech, Inc. (SNES)
About SenesTech, Inc.
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.19M | 1.02M | 576.00K | 258.00K | 143.00K | 297.00K | 52.00K | 318.00K | 241.00K | 199.00K |
| Cost of Revenue | 654.00K | 555.00K | 356.00K | 281.00K | 101.00K | 241.00K | 45.00K | 196.00K | 0.00 | 0.00 |
| Gross Profit | 539.00K | 464.00K | 220.00K | -23.00K | 42.00K | 56.00K | 7.00K | 122.00K | 241.00K | 199.00K |
| Gross Profit Ratio | 45.18% | 45.53% | 38.19% | -8.91% | 29.37% | 18.86% | 13.46% | 38.36% | 100.00% | 100.00% |
| Research & Development | 1.23M | 1.86M | 1.95M | 1.49M | 1.91M | 2.40M | 3.19M | 2.71M | 7.22M | 3.20M |
| General & Administrative | 6.70M | 7.59M | 7.22M | 6.44M | 0.00 | 9.53M | 9.13M | 8.13M | 8.67M | 2.70M |
| Selling & Marketing | 317.00K | 631.00K | 584.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 7.02M | 8.28M | 7.22M | 6.44M | 8.42M | 9.53M | 9.13M | 8.13M | 8.67M | 2.70M |
| Other Expenses | 27.00K | -26.00K | -24.00K | -24.00K | 266.00K | 21.00K | 87.00K | -31.00K | -678.00K | 31.00K |
| Operating Expenses | 8.27M | 10.14M | 9.15M | 7.91M | 10.33M | 11.94M | 12.32M | 10.83M | 15.89M | 5.90M |
| Cost & Expenses | 8.93M | 10.69M | 9.51M | 8.19M | 10.43M | 12.18M | 12.37M | 10.83M | 15.89M | 5.90M |
| Interest Income | 26.00K | 7.00K | 4.00K | 3.00K | 45.00K | 25.00K | 29.00K | 0.00 | 0.00 | 0.00 |
| Interest Expense | 4.00K | 2.00K | 11.00K | 28.00K | 42.00K | 74.00K | 86.00K | 87.00K | 855.00K | 632.00K |
| Depreciation & Amortization | 135.00K | 183.00K | 303.00K | 288.00K | 413.00K | 447.00K | 391.00K | 196.00K | 182.00K | 125.00K |
| EBITDA | -7.57M | -9.51M | -7.95M | -7.62M | -9.56M | -11.39M | -11.81M | -10.51M | -17.14M | -6.44M |
| EBITDA Ratio | -634.62% | -951.23% | -1,550.35% | -3,065.50% | -6,687.41% | -3,834.01% | -22,709.62% | -3,255.03% | -6,697.51% | -2,784.42% |
| Operating Income | -7.73M | -9.67M | -8.93M | -7.93M | -10.29M | -11.88M | -12.32M | -10.52M | -15.65M | -5.70M |
| Operating Income Ratio | -648.11% | -949.36% | -1,551.04% | -3,074.81% | -7,193.71% | -4,000.00% | -23,684.62% | -3,306.92% | -6,491.70% | -2,862.81% |
| Total Other Income/Expenses | 22.00K | -21.00K | 666.00K | -4.00K | 269.00K | -28.00K | 30.00K | -279.00K | -2.53M | -1.50M |
| Income Before Tax | -7.71M | -9.70M | -8.27M | -7.94M | -10.02M | -11.91M | -12.29M | -10.80M | -18.17M | -7.20M |
| Income Before Tax Ratio | -646.27% | -951.42% | -1,435.42% | -3,076.36% | -7,005.59% | -4,009.43% | -23,626.92% | -3,394.65% | -7,540.66% | -3,618.09% |
| Income Tax Expense | 0.00 | 19.00K | -292.00K | -239.00K | 308.00K | 46.00K | 173.00K | 56.00K | 177.00K | 663.00K |
| Net Income | -7.71M | -9.71M | -7.98M | -7.70M | -10.33M | -11.91M | -12.29M | -10.80M | -18.17M | -7.20M |
| Net Income Ratio | -646.27% | -953.29% | -1,384.72% | -2,983.72% | -7,220.98% | -4,009.43% | -23,626.92% | -3,394.65% | -7,540.66% | -3,618.09% |
| EPS | -11.51 | -186.39 | -171.04 | -614.56 | -1.90K | -245.50 | -450.00 | -672.84 | -1.09K | -403.93 |
| EPS Diluted | -115.10 | -186.39 | -171.04 | -614.56 | -1.90K | -245.50 | -450.00 | -672.84 | -1.09K | -403.93 |
| Weighted Avg Shares Out | 669.85K | 52.12K | 46.63K | 12.53K | 5.43K | 48.51K | 27.30K | 16.04K | 16.65K | 17.83K |
| Weighted Avg Shares Out (Dil) | 66.99K | 52.12K | 46.63K | 12.53K | 5.43K | 48.51K | 27.30K | 16.04K | 16.65K | 17.83K |
Senestech, Inc. (SNES) Reports Q2 Loss, Lags Revenue Estimates
Senestech, Inc. (SNES) delivered earnings and revenue surprises of -10.53% and 24.52%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
SenesTech's (SNES) CEO Ken Siegel on Q1 2022 Results - Earnings Call Transcript
SenesTech, Inc. (NASDAQ:SNES ) Q1 2022 Earnings Conference Call May 12, 2022 5:00 PM ET Company Participants Robert Blum – Managing Partner-Lytham Partners Ken Siegel – Chief Executive Officer Tom Chesterman – Chief Financial Officer Conference Call Participants Tucker Andersen...
SenesTech, Inc. (SNES) CEO Kenneth Siegel on Q4 2021 Results - Earnings Call Transcript
SenesTech, Inc. (SNES) CEO Kenneth Siegel on Q4 2021 Results - Earnings Call Transcript
SenesTech to Report Fourth Quarter and Fiscal Year 2021 Financial Results on Tuesday, March 29, 2022
Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET PHOENIX , March 23, 2022 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its fourth quarter and fiscal year 2021,...
Here's Why SenesTech Shares Are Rising
SenesTech Inc (NASDAQ: SNES) shares are trading higher by 22.2% at $0.88 after the company announced the EPA approval of and launch of the Elevate Bait System with ContraPest. SenesTech says the bait system is specifically designed to be easily...
SenesTech to Participate in the Lytham Partners Winter 2021 Investor Conference
PHOENIX, Dec. 6, 2021 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today that it will be participating in the Lytham Partners Winter 2021 Investor Conference taking place from December...
SenesTech's (SNES) CEO Ken Siegel on Q3 2021 Results - Earnings Call Transcript
SenesTech's (SNES) CEO Ken Siegel on Q3 2021 Results - Earnings Call Transcript
SenesTech to Present at the Lytham Partners Fall 2021 Investor Conference
PHOENIX, Sept. 30, 2021 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced today that it will present at the Lytham Partners Fall 2021 Investor Conference on Thursday, October 7,...
SenesTech's (SNES) CEO Ken Siegel on Q2 2021 Results - Earnings Call Transcript
SenesTech's (SNES) CEO Ken Siegel on Q2 2021 Results - Earnings Call Transcript
SenesTech to Report Second Quarter 2021 Financial Results on Thursday, August 12, 2021
PHOENIX, Aug. 3, 2021 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, will report financial results for its second quarter 2021, ended June 30, 2021, after the market close...
Source: https://incomestatements.info
Category: Stock Reports